IPO Listed
IMPACT Therapeutics IPO
HK$844m raised
Lodged 13 May 2026 · HKEX: 7630
Advisers
IMPACT Therapeutics
Issuer
- Legal adviser
- Cooley
Team: Yiming Liu, Michael Yu, Hilda Li, Ying Liu, Xinwei Li, Daniel Zheng
Lead managers
- Lead manager
- Goldman Sachs
(co)CICC (co) - Joint lead manager
- Goldman Sachs
(co)CICC (co) - Bookrunner
- Goldman Sachs
(co)CICC (co) - Legal adviser
- Joint sponsors
- Goldman Sachs
(co)CICC (co)
- Issuer
- IMPACT Therapeutics
- Issuer based in
- China
- Listed
- 13 May 2026
- Sector
- Biotech
- Tags
- Biotech, Oncology, Drug Development
Similar deals
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- Parabilis Medicines IPO Jun 2026 · US$670m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
Sources
- 13 May 2026 IMPACT Therapeutics Announces HK$844 Million IPO cooley.com
- 13 May 2026 Kirkland Assists Impact Therapeutics on its Hong Kong IPO kirkland.com
